|
|
Volumn 4, Issue 8, 2016, Pages 651-
|
|
Research digest
a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EMPAGLIFLOZIN;
HEMOGLOBIN A1C;
INSULIN;
LIRAGLUTIDE;
LIXISENATIDE;
PLACEBO;
SULFONYLUREA DERIVATIVE;
ANTIDIABETIC AGENT;
BENZHYDRYL DERIVATIVE;
GLUCOSIDE;
ACUTE CORONARY SYNDROME;
ALBUMINURIA;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR MORTALITY;
CARDIOVASCULAR RISK;
CEREBROVASCULAR ACCIDENT;
DIABETES MELLITUS;
DISEASE COURSE;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG SAFETY;
ESTIMATED GLOMERULAR FILTRATION RATE;
GALLSTONE;
GLYCEMIC CONTROL;
HEART FAILURE;
HEART INFARCTION;
HIGH RISK PATIENT;
HUMAN;
HYPOGLYCEMIA;
KIDNEY DISEASE;
KIDNEY FAILURE;
MACROALBUMINURIA;
MICROALBUMINURIA;
NAUSEA AND VOMITING;
NOTE;
PANCREATITIS;
PRIORITY JOURNAL;
RISK REDUCTION;
SECONDARY PREVENTION;
TREATMENT RESPONSE;
CLINICAL TRIAL (TOPIC);
DRUG EFFECTS;
GLOMERULUS FILTRATION RATE;
PHYSIOLOGY;
PROCEDURES;
BENZHYDRYL COMPOUNDS;
CARDIOVASCULAR DISEASES;
CLINICAL TRIALS AS TOPIC;
DIABETES MELLITUS;
GLOMERULAR FILTRATION RATE;
GLUCOSIDES;
HUMANS;
HYPOGLYCEMIC AGENTS;
LIRAGLUTIDE;
|
|
EID: 84989950757
PISSN: 22138587
EISSN: 22138595
Source Type: Journal
DOI: 10.1016/S2213-8587(16)30161-9 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|